NeoGen PSR
Restoring and regenerating the skin’s natural architecture
Unique Deep Tissue Remodelling with Rapid Healing.
NeoGen PSR offers a range of treatment options, and delivers the unparalleled results your patients expect.
​
The unique energy delivered by NeoGen is non-fractionated and not dependant on a chromophore for its uptake. This provides uniform energy absorption, ensuring consistent treatment of the skin, and at high energies supporting significant tightening.
​
NeoGen PSR System
NeoGen nitrogen plasma technology delivers controlled heating to the skin architecture stimulating a significant physiological response, without creating an open wound. Unlike ablative technologies there is no epidermal vaporisation or charring caused at time of treatment.
​
Unique Technology
NeoGen converts nitrogen gas into plasma energy, the fourth state of matter. The plasma emerges from the handpiece in controlled pulses and rapid heating of tissue occurs as it gives up its unique thermal energy to tissue.
No Open Wounds
The treated photodamaged layers undergo a controlled thermal modification, while remaining intact, creating a natural dressing to provide protection and speed healing. at high energies the epidermis sheds, but only after a new, healthier skin architecture is formed beneath.
Treats the Whole Skin Architecture
Treating the entire skin structure ensures optimal results as the entire surface is regenerated with associated neocollagenesis and neoelastogenesis. No islands of untreated skin remain. Clinical studies show significant tightening – Mean 22% improvement in upper eyelid tightening (JOCD 7, 169-179, 2008).
Eyelids and Periorbital Treatment
NeoGen is the ideal option for the treatment of the upper and lower eyelids, as well as the wider periorbital region. Other technologies cannot be used in this area or deliver inconsistent results.
Long Lasting Results
Clinical studies show neocollagenesis and reduction in elastosis continuing for more than one year post treatment.
Note: NeoGen PSR – Indications for use in treatment of the following dermatological conditions: Wrinkles and rhytides, Superficial skin lesions, Actinic Keratosis, Viral Papillomata, Seborrheic Keratosis, Acne Scars.
FDA Indications for use statement reference K132754